These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10708212)

  • 1. Coagulation activation in sepsis.
    Kaplan KL
    Crit Care Med; 2000 Feb; 28(2):585-6. PubMed ID: 10708212
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical expert round table discussion (session 4) at the Margaux Conference on Critical Illness: sepsis: inflammation disorder, coagulation disorder, or both? A challenge for clinicians.
    Carlet J; Taylor F; Levi M; Artigas A; ten Cate H; Marshall J
    Crit Care Med; 2001 Jul; 29(7 Suppl):S107-8. PubMed ID: 11445743
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation system and platelets are fully activated in uncomplicated sepsis.
    Mavrommatis AC; Theodoridis T; Orfanidou A; Roussos C; Christopoulou-Kokkinou V; Zakynthinos S
    Crit Care Med; 2000 Feb; 28(2):451-7. PubMed ID: 10708182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.
    Dhainaut JF; Shorr AF; Macias WL; Kollef MJ; Levi M; Reinhart K; Nelson DR
    Crit Care Med; 2005 Feb; 33(2):341-8. PubMed ID: 15699837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?
    Boldt J; Papsdorf M; Rothe A; Kumle B; Piper S
    Crit Care Med; 2000 Feb; 28(2):445-50. PubMed ID: 10708181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical expert round table discussion (session 5) at the Margaux Conference on Critical Illness: outcomes of clinical trials in sepsis: lessons learned.
    Vincent JL; Angus D; Annane D; Bernard G; Faist E; Giroir B; Reinhart K
    Crit Care Med; 2001 Jul; 29(7 Suppl):S136-7. PubMed ID: 11445749
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial cell dysfunction and coagulation.
    Vallet B; Wiel E
    Crit Care Med; 2001 Jul; 29(7 Suppl):S36-41. PubMed ID: 11445732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic response to sepsis: interaction between coagulation and inflammatory processes.
    Dhainaut JF; Marin N; Mignon A; Vinsonneau C
    Crit Care Med; 2001 Jul; 29(7 Suppl):S42-7. PubMed ID: 11445733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Would patients with more subtle signs of coagulopathy have benefited from treatment with activated protein C?
    Benoit DD; Depuydt PO; De Waele JJ; Hoste EA; Colpaert KE; Van Hende VD; Decruyenaere JM
    Crit Care Med; 2005 Jul; 33(7):1670; author reply 1670-1. PubMed ID: 16003095
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: the role of activated protein C in severe sepsis.
    Bernard G; Artigas A; Dellinger P; Esmon C; Faist E; Faust SN; Fischer CJ; Fumagalli R; grinnell BW; Sprung C
    Crit Care Med; 2001 Jul; 29(7 Suppl):S75-7. PubMed ID: 11445738
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of activated protein C is detrimental during severe experimental gram-negative sepsis (melioidosis).
    Kager LM; Wiersinga WJ; Roelofs JJ; de Boer OJ; Meijers JC; Isermann B; van't Veer C; Van der Poll T
    Crit Care Med; 2013 Oct; 41(10):e266-74. PubMed ID: 23887233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy in sepsis - a new look at an old problem.
    Lipinska-Gediga M
    Anaesthesiol Intensive Ther; 2016; 48(5):352-359. PubMed ID: 27824218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation abnormalities in acute lung injury and sepsis.
    Abraham E
    Am J Respir Cell Mol Biol; 2000 Apr; 22(4):401-4. PubMed ID: 10745020
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood coagulation factor activity in experimental endotoxemia.
    West RL; Elovitz MJ; Hardaway RM
    Ann Surg; 1966 Apr; 163(4):567-72. PubMed ID: 5934633
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulopathy of sepsis from nonspecific inhibitors.
    Thachil J
    Int J Lab Hematol; 2015 Dec; 37(6):e170-1. PubMed ID: 26767938
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting the course of sepsis: the next step?
    Knöbl P
    Crit Care Med; 2005 Feb; 33(2):450-2. PubMed ID: 15699856
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of coagulation disorders with thrombelastography in patients with sepsis].
    Zhong S; Zhang C; Hu J; Tang Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):153-8. PubMed ID: 26911948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis.
    Aird WC
    Crit Care Med; 2001 Jul; 29(7 Suppl):S28-34; discussion S34-5. PubMed ID: 11445731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome.
    Marshall JC
    Crit Care Med; 2001 Jul; 29(7 Suppl):S99-106. PubMed ID: 11445742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.